Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31681090 | 0.88 | CYP19A1 (0.39) | EPHX2CYP19A1CYP17A1ALDH1A1LMNA | |
| SCHEMBL20261866 | 0.82 | CYP19A1 (0.35) | EPHX2CYP19A1CYP17A1ALDH1A1LMNA | |
| SCHEMBL7038407 | 0.81 | CYP19A1 (0.37) | EPHX2CYP19A1CYP17A1ALDH1A1LMNA | |
| SCHEMBL13113326 | 0.81 | EPHX2 (0.39) | EPHX2CYP19A1 | |
| SCHEMBL12003303 | 0.79 | CYP19A1 (0.35) | EPHX2CYP19A1CYP17A1ALDH1A1NAAA | |
| SCHEMBL23474830 | 0.78 | TSHR (0.46) | EPHX2CYP19A1 | |
| SCHEMBL13113296 | 0.78 | CYP19A1 (0.37) | EPHX2CYP19A1CYP17A1ALDH1A1HTT | |
| SCHEMBL23489581 | 0.78 | LMNA (0.32) | ALDH1A1LMNA | |
| SCHEMBL23474724 | 0.77 | ALDH1A1 (0.32) | EPHX2ALDH1A1 | |
| SCHEMBL1271393 | 0.76 | CYP19A1 (0.40) | EPHX2CYP19A1CYP17A1ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11987658-B2 | Curable resin composition and method of manufacturing article | CANON KABUSHIKI KAISHA (JP) | 2024-05-21 | — | — | US | disclosed |
| WO-2023248976-A1 | POLYMER AND METHOD FOR PRODUCING SAME, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, AND MONOMER COMPOUND AND METHOD FOR PRODUCING SAME | 株式会社日本触媒 | 2023-12-28 | — | — | WO | disclosed |
| WO-2023195398-A1 | ADHESIVE COMPOSITION, ADHESIVE FILM FOR CIRCUIT CONNECTION, CIRCUIT CONNECTION STRUCTURE, AND METHOD OF PRODUCING SAME | 株式会社レゾナック | 2023-10-12 | — | — | WO | disclosed |
| US-20220282013-A1 | CURABLE RESIN COMPOSITION AND METHOD OF MANUFACTURING ARTICLE | CANON KABUSHIKI KAISHA (JP) | 2022-09-08 | — | — | US | disclosed |
| WO-2020162475-A1 | CURABLE RESIN COMPOSITION | キヤノン株式会社 | 2020-08-13 | — | — | WO | disclosed |
| US-10449124-B2 | Polymerizable composition for dental use | GC CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20180221251-A1 | POLYMERIZABLE COMPOSITION FOR DENTAL USE | GC CORPORATION (JP) | 2018-08-09 | — | — | US | disclosed |
| EP-3335688-A1 | POLYMERIZABLE DENTAL COMPOSITION | GC Corporation (JP) | 2018-06-20 | — | — | EP | disclosed |
| US-20180037758-A1 | Ink Composition For Three-Dimensional Modeling, Ink Set, And Method For Producing Three-Dimensional Model | Konica Minolta, Inc. (JP) | 2018-02-08 | — | — | US | disclosed |
| EP-2415751-B1 | ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | NIPPON CATALYTIC CHEM IND (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-8796492-B2 | α-(unsaturated alkoxyalkyl) acrylate composition and process for production thereof | NIPPON SHOKUBAI CO., LTD. (JP) | 2014-08-05 | — | — | US | disclosed |
| EP-2415751-A1 | ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | Nippon Shokubai Co., Ltd. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120016095-A1 | a-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180221251-A1 | POLYMERIZABLE COMPOSITION FOR DENTAL USE | CAD, MDN1, PAM | EPHX2 1070/4885CYP19A1 4007/4885CYP17A1 4161/4885 |
| US-10449124-B2 | Polymerizable composition for dental use | CAD, MDN1, PAM | EPHX2 1070/4885CYP19A1 4007/4885CYP17A1 4161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.